scispace - formally typeset
S

Shohreh Issazadeh-Navikas

Researcher at University of Copenhagen

Publications -  63
Citations -  8825

Shohreh Issazadeh-Navikas is an academic researcher from University of Copenhagen. The author has contributed to research in topics: T cell & Natural killer T cell. The author has an hindex of 23, co-authored 63 publications receiving 7228 citations. Previous affiliations of Shohreh Issazadeh-Navikas include Lund University.

Papers
More filters
Journal ArticleDOI

CD1d-Dependent NKT Cells Play a Protective Role in Acute and Chronic Arthritis Models by Ameliorating Antigen-Specific Th1 Responses

TL;DR: Support is provided for CD1d-dependent NKTs being suppressor cells in acute and chronic arthritis, likely via inhibition of arthritogenic Th1 cells, which makes CD1D-dependentNKTs an attractive target for therapeutic intervention.
Journal ArticleDOI

pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation.

TL;DR: It is shown that pDCs transferred during acute disease phase confer recovery from EAE, and this study may pave the way for novel pDC-based cell therapies in autoimmune diseases, aiming at specifically modulating pathogenic cells that induce and sustain autoimmune inflammation.
Journal ArticleDOI

Neuronal IFN-beta–induced PI3K/Akt-FoxA1 signalling is essential for generation of FoxA1 + T reg cells

TL;DR: It is shown that lack of neuronal IFNβ signalling is associated with the absence of programme death ligand-1 (PDL1), which prevents their ability to reprogramme Tenc cells to FoxA1+Tregs.
Journal ArticleDOI

Interferon-β-induced miR-1 alleviates toxic protein accumulation by controlling autophagy.

TL;DR: It is reported that the microRNA miR-1 regulates the autophagy pathway through conserved targeting of the orthologous Tre-2/Bub2/CDC16 (TBC) Rab GTPase-activating proteins TBC-7 and TBC1D15 in Caenorhabditis elegans and mammalian cells, respectively.